Skip to content
#gene editing Review Open access

Applications of synthetic biology in biomedicine

Aug 2026 · Molecular Biomedicine · Vol 7 · 0 citations · 277 references
Medicine

TL;DR

This review systematically summarizes progress in foundational tools and key supporting technologies of synthetic biology, highlights innovative strategies and clinical value in biosensors, cell therapy, living therapeutics, and smart biomaterials, and provides an in-depth comparison of different chassis cells, delivery vectors, and regulatory circuits in terms of disease suitability, safety, and translational efficiency.

Abstract

Based on the principles of engineering reconstruction and programmable design, synthetic biology is driving a paradigm shift in biomedical diagnosis and therapy from conventional models toward intelligent and precision medicine. By constructing artificial genetic circuits, functional cells, and biomaterial systems both in vitro and in vivo, synthetic biology markedly enhances diagnostic sensitivity, therapeutic targeting, and clinical benefit. In recent years, with the maturation of key technologies such as DNA synthesis and assembly, computational modeling, gene editing, RNA regulation, and protein engineering, synthetic biology has spawned numerous applications with potential for clinical translation in fields such as early screening for pathogens and tumors, programmable cellular immunotherapies, intelligent life-based therapies, and the manufacture of medical biomaterials. Nevertheless, current synthetic biology systems still face critical bottlenecks such as insufficient targeting and editing precision in vivo, poor functional stability of gene circuits, pronounced immunogenicity risks, high manufacturing costs, and lagging ethical and regulatory frameworks. This review systematically summarizes progress in foundational tools and key supporting technologies of synthetic biology, highlights innovative strategies and clinical value in biosensors, cell therapy, living therapeutics, and smart biomaterials, and provides an in‑depth comparison of different chassis cells, delivery vectors, and regulatory circuits in terms of disease suitability, safety, and translational efficiency. The artificial intelligence (AI)-enabled component design, closed-loop intelligent regulation, off‑the‑shelf universal cells, and multimodal theranostic platforms are also discussed. This review offers a systematic framework from technical principles to clinical translation and provides theoretical support and technical guidance for developing next-generation synthetic biology-based diagnostic and therapeutic strategies.

Read PDF

Similar papers

Open access Jul 2026

Engineering the future of advanced therapy medicinal products: a bioengineering call to action

This Perspective, grounded in clinical experience across hematological malignancies, monogenic diseases, and metabolic disorders, identifies five rate-limiting bottlenecks where bioengineering intervention is urgently needed and uniquely tractable: scalable and adaptive biomanufacturing.

Giulia Nieri, Anna Spiller, Stella Federico et al. · 0 citations
Review Aug 2026

Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer.

This review highlights chassis selection, circuit architectures, applications for metabolic diseases and cancer, metabolic bottlenecks, and future directions for precision microbial therapeutics for metabolic disorders and oncology.

B. Onoja, S. Agada, Waheeb S. Aggad et al. · 0 citations
Review Open access Jul 2026

Exosome Nanotechnology in Molecular Medicine: Advances, Applications and Challenges in Gene Therapy

Despite their promise, significant challenges remain, including low cargo-loading efficiency, batch heterogeneity, limited scalability and the absence of standardized manufacturing and regulatory frameworks, future research must address these barriers to accelerate the clinical translation of exosome-based therapeutics...

Elza Karabagh, Babek Alibayov, Adil Allahverdiyev · 0 citations
Review Open access Jul 2026

Synthetic biology and genome engineering in support of human, agricultural, and environmental security

The rapid pace of innovation in synthetic biology and genome engineering elicits a need to reevaluate systems of oversight to ensure that biosafety and biosecurity safeguards are keeping up. Accordingly, the regulation of nucleic acid synthesis, an enabling technology for synthetic biology and genome engineering, is a...

C. Chapman, Julie Trolle, Dominika Wawrzyniak et al. · 0 citations
Review Aug 2026

Engineered microorganisms and nanomaterials in cancer therapy: Emerging hybrid systems and translational challenges.

The integration of engineered microorganisms and nanomaterials represents a promising strategy for next-generation precision oncology and may accelerate the development of more effective and personalized cancer therapies.

Yuxi Cheng, Shenhan Yu, Ying Huang et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.